Request a Demo Log In
Faulkner v. Acella Pharmaceuticals, LLC, Docket No. 2:22-cv-00092 (N.D. Ga. May 12, 2022), Court Docket
X1Q6OE9MSA82
DOCKETS
Faulkner v. Acella Pharmaceuticals, LLC

Search

Search over:

No Matches Found

Search term(s) not found.

Docket Entries Since Last Update
NOTE: This court's RSS feed does not list MOTION entries, so Bloomberg Law cannot detect them and thus they will not be listed here. However, motions will be included if you update the docket.

Copy with Citation

Copy the text below to paste into your document.

Link citations to Bloomberg Law
Court Dockets
gand
U.S. District Court
Northern District of Georgia (Gainesville)
CIVIL DOCKET FOR CASE #: 2:22-cv-00092-RWS

Faulkner v. Acella Pharmaceuticals, LLC

DOCKET INFORMATION
Minimize
Date Filed: May 12, 2022
Nature of suit:470 Racketeer/Corrupt Organization
Assigned to:Judge Richard W. Story
Cause:18:1964 Racketeering (RICO) Act
Jurisdiction:Diversity
Jury demand:Plaintiff

Parties and Attorneys

Expand AllMinimize
Expand All
Hide Section

 Plaintiff
Sue Faulkner
on behalf of herself and all others similarly situated
Plaintiff
Representation
Aaron Karl Block
The Block Firm
309 East Paces Ferry Road
Suite 400
Atlanta, GA 30305
(404) 997-8419
aaron@blockfirmllc.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Allison Brennan Bailey
Block Firm LLC
309 East Paces Ferry Rd
Ste 400
Atlanta, GA 30305
(404) 997-8419
allison.bailey@blockfirmllc.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Max Paul Marks
The Block Firm, LLC
309 East Paces Ferry Rd.
Suite 400
Atlanta, GA 30305
(404) 919-5320
max.marks@blockfirmllc.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

 Defendant
Acella Pharmaceuticals, LLC
Defendant
Representation
David F. Norden
Troutman Pepper Hamilton Sanders LLP
600 Peachtree Street
Suite 3000
Atlanta, GA 30308
(404) 885-3608
Fax: (404) 885-3900
david.norden@troutman.com
ATTORNEY TO BE NOTICED

Docket Entries

Reverse Entries
Hide Section
Print Entries Request Entries Reverse Entries
Numbers shown are court assigned numbers.

EntryFiledPDFDescription
1May 12, 2022ViewCOMPLAINT, with Jury Demand, filed by Sue Faulkner. (Filing fee $402, receipt number AGANDC-11800597) (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1- Acellas Amended Complaint in Acella Pharm., LLC v. Westminster Pharm, # 3 Exhibit 2- Form FDA 483 related to December 2019 and January 2020 inspection, # 4 Exhibit 3- August 14, 2020 FDA Warning Letter to Acella, # 5 Exhibit 4- Establishment Inspection Report for the FDAs December 2019 through Ja, # 6 Exhibit 5- FDA webpage titled Recalls Background and Definitions, # 7 Exhibit 6-Acellas description of NP Thyroid (THYROID TABLETS, USP), # 8 Exhibit 7- October 6, 2017 Cease and Desist Letter from Acella to Westminster, # 9 Exhibit 8- Response to Acellas Cease and Desist Letter, # 10 Exhibit 9- Acella marketing material titled NP Thyroid: A Natural Choice for Thy, # 11 Exhibit 10- marketing materials titled A Natural Choice for Thyroid Therapy, # 12 Exhibit 11- marketing materials titled NP Thyroid May Help You Change Your Perspective, # 13 Exhibit 12- Screenshot of the homepage of https://npthyroid.com, # 14 Exhibit 13- Screenshot of the For Patients section of Acellas NP Thyroid website, # 15 Exhibit 14- Acellas March 31, 2020 Letter to the FDA, # 16 Exhibit 15- January 27, 2021 FDA Warning Letter to Allay, # 17 Exhibit 16- Acellas First Recall Announcement, # 18 Exhibit 17- FDA National Drug Code Directory results for NP Thyroid, # 19 Exhibit 18- FDA Announcement of Acellas Second Recall, # 20 Exhibit 19- FDA Announcement of Acellas Third Recall, # 21 Exhibit 20- Screenshot of FDAs Firm Profile for Acella)(ddm) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. (Entered: 05/13/2022)
2May 13, 2022RequestElectronic Summons Issued as to Acella Pharmaceuticals, LLC. (ddm) (Entered: 05/13/2022)
3May 16, 2022RequestCOURT NOTICE of Filing: Standing Order regarding Civil Litigation by Judge Richard W. Story. (sk) (Entered: 05/16/2022)
4May 19, 2022RequestReturn of Service Executed by Sue Faulkner. Acella Pharmaceuticals, LLC served on 5/18/2022, answer due 6/8/2022. (Marks, Max) (Entered: 05/19/2022)
5May 27, 2022RequestConsent MOTION for Extension of Time to Respond to Plaintiff's Complaint re: 1 Complaint,,,,,,, by Acella Pharmaceuticals, LLC. (Attachments: # 1 Text of Proposed Order)(Norden, David) (Entered: 05/27/2022)
6May 31, 2022RequestORDER granting the parties' 5 Consent Motion for Extension of Time, to and including August 5, 2022, for Defendant to respond to respond to 1 Plaintiff's Complaint. Signed by Judge Richard W. Story on 05/27/2022. (ddm) (Entered: 05/31/2022)

Jump To
Please enter a valid page number
Pagination
Show Pagination
 

back to top

Enter a Client Matter

Your firm optionally allows a client matter to be selected while you are using Bloomberg Law. Please contact your administrator if you have any questions. Please select from a recently used Client Matter or enter a Client Matter manually.
RECENTLY USED
CLIENT MATTER
Please contact your administrator if you have questions about client matter.
Cancel Submit
Unrecognized Client Matter

Client Matter   does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
Bloomberg Industry Group
About Us Contact Us
Other Products
Big Law Business Professional Learning BNA
Help Topics
Getting Started BCite Citator Smart Code Points of Law Browse All Help Topics
24/7 BLAW® Help Desk
888.560.2529
help@bloomberglaw.com
0.1437.0
Terms of Service Privacy Policy Copyright Accessibility
© 2022 The Bureau of National Affairs, Inc. All Rights Reserved.